The Value of Genetic and Genomic Technologies: Workshop Summary (2010)
Chapter: Appendix A: Workshop Agenda
Appendix A
Workshop Agenda
The Value of Genetic and Genomic Technologies
The Beckman Center of the National Academies
100 Academy
Irvine, CA
March 22, 2010
MEETING OBJECTIVE
To examine the perceived value of genetic and genomic technologies, both present and future, in clinical practice
-
How do different stakeholders define the value of genetic and genomic technologies?
-
How do stakeholders evaluate the weight of one kind of value in relation to another?
-
How do people assess relative values to make health care decisions?
-
How do these types of values relate, or not relate, to the monetary cost of the technologies?
|
8:00–8:15 A.M. |
PUBLIC WORKSHOP BEGINS—AUDITORIUM |
|
8:00–8:15 A.M. |
Welcome and Introductory Remarks |
|
|
Wylie Burke, Roundtable Chair and Professor and Chair of the Department of Bioethics and Humanities, University of Washington |
|
8:15–10:15 A.M. |
CORRELATIONBETWEEN LYNCH SYNDROMEAND COLON CANCER |
|
8:15–8:30 A.M. |
Case Study Presentation |
|
|
Marc Williams, Director, Intermountain Healthcare Clinical Genetics Institute, LDS Hospital |
|
8:30–9:00 A.M. |
Lynch Syndrome Panelists |
|
|
Mark Boguski, Associate Professor, Center for Biomedical Informatics, Harvard Medical School Roy Gandolfi, Associate Medical Director, SelectHealth Don Lyman, Chief, Chronic Disease and Injury Control Division, California Department of Public Health Dennis Salisbury, Family Practice Physician, Rocky Mountain Clinic, Butte, MT Andrew Spiegel, CEO, Colon Cancer Alliance |
|
9:00–9:45 A.M. |
Panel discussion |
|
9:45–10:15 A.M. |
Roundtable discussion |
|
10:15–10:30 A.M. |
BREAK |
|
10:30–12:30 P.M. |
PHARMACOGENOMIC TESTING FOR WARFARIN DOSING |
|
10:30–10:45 A.M. |
Case Study Presentation |
|
|
David Veenstra, Associate Professor, Pharmaceutical Outcomes Research and Policy Program and Institute for Public Health Genetics, University of Washington |
|
10:45–11:15 A.M. |
Warfarin Panelists |
|
|
Anna Garrett, Manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, NC |
|
|
Arthur Lurvey, Medical Director, Palmetto GBA Elizabeth Mansfield, Director of the Personalized Medicine Staff, Office of In Vitro Diagnostic Devices, Center for Devices and Radiological Health, FDA Dennis Salisbury, Family Practice Physician, Rocky Mountain Clinic, Butte, MT |
|
11:15 A.M.–12:00 P.M. |
Panel discussion |
|
12:00–12:30 P.M. |
Roundtable discussion |
|
12:30–1:30 P.M. |
LUNCH |
|
1:30–4:00 P.M. |
GENOMIC PROFILING |
|
1:30–1:45 P.M. |
Case Study Presentation |
|
|
Bruce Blumberg, Co-Chief of Medical Genetics, Kaiser Permanente, Oakland and Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente, The Permanente Medical Group |
|
1:45–2:15 P.M. |
Genomic Profiling Panelists |
|
|
Karen Kaplan, Science Writer, Los Angeles Times Vance Vanier, CEO and President, Navigenics Janet Williams, Genetic Counselor, Intermountain Healthcare, Oncology Clinics David Witt, Genetics Department, Kaiser San Jose Medical Center Steven Woolf, Professor, Departments of Family Medicine, Epidemiology, and Community Health, Virginia Commonwealth University |
|
2:15–3:15 P.M. |
Panel discussion |
|
3:15–4:00 P.M. |
Roundtable discussion |
|
4:00–5:00 P.M. |
SUMMARY |
|
4:00–5:00 P.M. |
Summary and wrap-up discussion |
|
|
Bruce Blumberg, Co-Chief of Medical Genetics, Kaiser Permanente, Oakland and Institutional Director of Graduate Medical Education, Northern California Kaiser Permanente, The Permanente Medical Group Wylie Burke, Roundtable Chair and Professor and Chair of the Department of Bioethics and Humanities, University of Washington Catherine A. Wicklund, Director of the Graduate Program in Genetic Counseling and Assistant Professor, Department of Obstetrics and Gynecology, Northwestern University Marc Williams, Director, Intermountain Healthcare Clinical Genetics Institute, LDS Hospital |
|
5:00 P.M. |
ADJOURN |
